De Martin S - Search Results

1

Obeticholic Acid for Primary Biliary Cholangitis.

Floreani A, Gabbia D, De Martin S. Floreani A, et al. Among authors: de martin s. Biomedicines. 2022 Oct 2;10(10):2464. doi: 10.3390/biomedicines10102464. Biomedicines. 2022. PMID: 36289726 Free PMC article. Review.

2

PCSK9 promotes arterial medial calcification.

Lupo MG, Bressan A, Donato M, Canzano P, Camera M, Poggio P, Greco MF, Garofalo M, De Martin S, Panighel G, Ruscica M, Baragetti A, Bollati V, Faggin E, Rattazzi M, Catapano AL, Ferri N. Lupo MG, et al. Among authors: de martin s. Atherosclerosis. 2022 Apr;346:86-97. doi: 10.1016/j.atherosclerosis.2022.01.015. Epub 2022 Jan 22. Atherosclerosis. 2022. PMID: 35135698

3

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases.

Guidetti C, Serra G, Pani L, Pappagallo M, Maglio G, Trasolini M, De Martin S, Mattarei A, Bifari F, Folli F, Manfredi PL, Fava M. Guidetti C, et al. Among authors: de martin s. J Clin Psychopharmacol. 2022 Sep-Oct 01;42(5):503-506. doi: 10.1097/JCP.0000000000001583. Epub 2022 Aug 6. J Clin Psychopharmacol. 2022. PMID: 35943402 Free PMC article. No abstract available.

4

Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.

De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P. De Martin S, et al. Clin Pharmacol Ther. 2006 Dec;80(6):597-606. doi: 10.1016/j.clpt.2006.08.020. Clin Pharmacol Ther. 2006. PMID: 17178261 Clinical Trial.

5

Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients.

Baldan N, Rigotti P, Furian L, Margani G, Ekser B, Frison L, De Martin S, Palatini P. Baldan N, et al. Among authors: de martin s. Pharmacol Res. 2006 Sep;54(3):181-5. doi: 10.1016/j.phrs.2006.04.006. Epub 2006 May 1. Pharmacol Res. 2006. PMID: 16750634

6

Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.

Orlando R, Padrini R, Perazzi M, De Martin S, Piccoli P, Palatini P. Orlando R, et al. Among authors: de martin s. Clin Pharmacol Ther. 2006 May;79(5):489-99. doi: 10.1016/j.clpt.2006.01.012. Clin Pharmacol Ther. 2006. PMID: 16678550 Clinical Trial.

7

The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update.

Palatini P, Orlando R, De Martin S. Palatini P, et al. Among authors: de martin s. Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1215-30. doi: 10.1517/17425255.2010.503704. Expert Opin Drug Metab Toxicol. 2010. PMID: 20604736 Review.

8

Nature of the critical labile event that controls RB phosphorylation in the cyclic AMP-dependent cell cycle of thyrocytes in primary culture.

Roger PP, Demartin S, Dumont JE. Roger PP, et al. Exp Cell Res. 1999 Nov 1;252(2):492-8. doi: 10.1006/excr.1999.4646. Exp Cell Res. 1999. PMID: 10527639

9

Enzyme inhibition and induction in liver disease.

Palatini P, De Martin S, Pegoraro P, Orlando R. Palatini P, et al. Among authors: de martin s. Curr Clin Pharmacol. 2008 Jan;3(1):56-69. doi: 10.2174/157488408783329896. Curr Clin Pharmacol. 2008. PMID: 18690879 Review.

10

Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function.

Orlando R, Piccoli P, De Martin S, Padrini R, Floreani M, Palatini P. Orlando R, et al. Among authors: de martin s. Clin Pharmacol Ther. 2004 Jan;75(1):80-8. doi: 10.1016/j.clpt.2003.09.007. Clin Pharmacol Ther. 2004. PMID: 14749694 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page